Novel CRTC1::MRTFB(MKL2) Gene Fusion Detected in Myxoid Mesenchymal Neoplasms With Myogenic Differentiation Involving Bone and Soft Tissues
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, kazuistiky
PubMed
38763420
DOI
10.1016/j.modpat.2024.100518
PII: S0893-3952(24)00098-X
Knihovny.cz E-zdroje
- Klíčová slova
- CRTC1::MRTFB, myogenic, myxoid mesenchymal tumor,
- MeSH
- buněčná diferenciace * MeSH
- dospělí MeSH
- fúze genů MeSH
- fúzní onkogenní proteiny genetika MeSH
- lidé MeSH
- nádorové biomarkery genetika analýza MeSH
- nádory kostí * genetika patologie MeSH
- nádory měkkých tkání * genetika patologie MeSH
- senioři MeSH
- trans-aktivátory genetika MeSH
- transkripční faktory * genetika MeSH
- vývoj svalů genetika MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- kazuistiky MeSH
- Názvy látek
- CRTC1 protein, human MeSH Prohlížeč
- fúzní onkogenní proteiny MeSH
- MRTFB protein, human MeSH Prohlížeč
- nádorové biomarkery MeSH
- trans-aktivátory MeSH
- transkripční faktory * MeSH
Appropriate classification of fusion-driven bone and soft tissue neoplasms continues to evolve, often relying on the careful integration of morphologic findings with immunohistochemical, molecular, and clinical data. Herein, we present 3 cases of a morphologically distinct myxoid mesenchymal neoplasm with myogenic differentiation and novel CRTC1::MRTFB (formerly MKL2) gene fusion. Three tumors occurred in 1 male and 2 female patients with a median age of 72 years (range: 28-78). Tumors involved the left iliac bone, the right thigh, and the left perianal region with a median size of 4.0 cm (4.0-7.6 cm). Although 1 tumor presented as an incidental finding, the other 2 tumors were noted, given their persistent growth. At the time of the last follow-up, 1 patient was alive with unresected disease at 6 months, 1 patient was alive without evidence of disease at 12 months after surgery, and 1 patient died of disease 24 months after diagnosis. On histologic sections, the tumors showed multinodular growth and were composed of variably cellular spindle to round-shaped cells with distinct brightly eosinophilic cytoplasm embedded within a myxoid stroma. One tumor showed overt smooth muscle differentiation. Cytologic atypia and mitotic activity ranged from minimal (2 cases) to high (1 case). By immunohistochemistry, the neoplastic cells expressed focal smooth muscle actin, h-caldesmon, and desmin in all tested cases. Skeletal muscle markers were negative. Next-generation sequencing detected nearly identical CRTC1::MRTFB gene fusions in all cases. We suggest that myxoid mesenchymal tumors with myogenic differentiation harboring a CRTC1::MRTFB fusion may represent a previously unrecognized, distinctive entity that involves soft tissue and bone. Continued identification of these novel myxoid neoplasms with myogenic differentiation will be important in determining appropriate classification, understanding biologic potential, and creating treatment paradigms.
Biopticka Laboratory Ltd Plzen Czech Republic
Department of Orthopedic Surgery Indiana University School of Medicine Indianapolis Indiana
Department of Pathology and Laboratory Medicine Cleveland Clinic Cleveland Ohio
Department of Pathology Indiana University School of Medicine Indianapolis Indiana
Department of Pathology Michigan University Ann Arbor Michigan
Department of Pathology The Johns Hopkins Hospital Baltimore Maryland
Citace poskytuje Crossref.org